Technology • NASDAQ
According to Zyberno, Astera Labs, Inc. (ALAB) is not a buy — GREAT BUSINESS (80/100) with a negative Margin of Safety of -100.0% and a Brina Gap of -39.6% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, Astera Labs, Inc. (ALAB) trades at $304.09 against an estimated intrinsic value per share of $67.51 — a -100.0% Margin of Safety based on Owner Earnings of $374.00M TTM, projected at 100.0% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -39.6% weakens the case: based on the company's ROIC (12.4%) and reinvestment rate (29.0%), the business can fundamentally grow at 3.6% — but the current enterprise value implies the market expects 43.2%. This places ALAB in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -11.2% annually.
Over the trailing twelve months, ALAB generated $374.00M in Owner Earnings. Capital was deployed as follows: $40.59M invested in capital expenditures. Reinvestment rate: 29.0%. Owner Earnings have grown at 100.0% annually over the trailing five years using log-linear regression.